Health Sciences (HSAC) Releases Shareholder Vote Results
Health Sciences Acquisition Corp. (HSAC), filed an 8-K this afternoon detailing the results of their recent shareholder vote to approve their business combination with Immunovant Sciences, Ltd., a clinical-stage biopharmaceutical company focused on autoimmune diseases.
As you can see below, shareholders overwhelming approved this transaction. No word yet on a closing date or new symbols, but it is expected that will be released shortly.
| FOR | AGAINST | ABSTAIN |
| 10,546,498 | 84,500 | 0 |
Unfortunately, we’ll have to wait for additional details, such as the number of redemptions, which should be filed in a later 8-K. An supplemental update will be provide once that information becomes available.